Fig. 8From: Tumor microenvironment responsive Mn3O4 nanoplatform for in vivo real-time monitoring of drug resistance and photothermal/chemodynamic synergistic therapy of gastric cancerIn vivo synergistic therapy. AÂ synergistic therapy strategy for 20 days. B Schematic diagram of in vivo synergistic therapy. CÂ Bioluminescence images of mice in each group within 20 days. D Photos of tumors in each group of mice. E H&E staining and TUNEL staining images of tumor sections of mice in each groupBack to article page